Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR.
Verschuuren
E A.
EA
University Hospital Groningen, Groningen, The Netherlands
Stevens
S
S
Hanekamp
B B.
BB
De Boer
C
C
Harmsen
M C.
MC
Middeldorp
J M.
JM
Koeter
G
G
The
T H.
TH
Van Der Bij
W
W